Stories > CASGEVY™: A Gene-Edited Therapy for Sickle Cell Disease

CASGEVY™: A Gene-Edited Therapy for Sickle Cell Disease

Advancements in Cell Therapies and Sickl...

Advancements in Cell Therapies and Sickl...

Advancements in Sickle Cell Disease Trea...

Biotech Collaboration for Industry Innov...

Biotech Collaboration for Innovative Sol...

Mesoblast's FDA Progress and Approvals